Click to view timeline
			
				
				Timeline
			
		Projects
Patents
Former Teams
Publications
Download- 
													
	2022The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella., ACS Cent Sci 2022 Apr; 8(4): 449-460.
- 
													
	2015Investigation on the synthesis of Shigella flexneri-specific oligosaccharides using disaccharides as potential transglucosylase acceptor substrates, J. Org. Chem. 2015 Sep;.
- 
													
	2013CGTase-catalysed cis-glucosylation of L-rhamnosides for the preparation of Shigella flexneri 2a and 3a haptens, Chembiochem 2014 Jan;15(2):293-300.
- 
													
	2013Concise synthesis of di- and trisaccharides related to the O-antigens from Shigella flexneri serotypes 6 and 6a, based on late stage mono-O-acetylation and/or site-selective oxydation, Tetrahedron 2013; 69:10337-50.
- 
													
	2013Structural studies of the O-acetyl containing O-antigen from a Shigella flexneri serotype 6 strain and synthesis of oligosaccharide fragments thereof, Eur. J. Org. Chem. 2013, 4085–106.
- 
													
	2008Synthesis of branched tri- to pentasaccharides representative of fragments of Shigella flexneri serotypes 3a and/or X O-antigens, Tetrahedron 2008; 64: 10558-72.
- 
													
	2004Total synthesis of a tetra- and two pentasaccharide fragments of the O-specific polysaccharide of Shigella flexneri serotype 2a, Tetrahedron 2004; 60: 2475-88.

 
																	

